Christine Erikstrup Hallgreen (Christine E Hallgreen)

Scopus Author ID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Therapeutic innovation & regulatory science

BMJ quality & safety

Clinical pharmacology and therapeutics

BMJ open

University of Copenhagen

Technical University of Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Copenhagen May 01 2015

Denmark

Assistant Professor :: Department of Pharmacy

University of Copenhagen Sep 01 2014 - Apr 30 2015

Denmark

Post. doc :: Department of Pharmacy

Imperial College London Apr 01 2013 - Aug 31 2014

United Kingdom

Research Fellow :: Imperial Clinical Trials Unit, School of Public Health

Education History

Technical University of Denmark Feb 01 2006

Denmark

PHD :: Department of Physics

Technical University of Denmark

Denmark

MSC :: Department of Physics

Publications

Richard L Morrow, Barbara J Mintzes, Patrick C Souverein, Marie L De Bruin, Elizabeth Ellen Roughead, Joel Lexchin, Anna Kemp-Casey, Lorri Puil, Ingrid Sketris, Dee Mangin, Christine Erikstrup Hallgreen, Sallie-Anne Pearson, Ruth Lopert, Lisa Bero, Richard Ofori-Asenso, Danijela Gnjidic, Ameet Sarpatwari, Lucy T Perry, Colin R Dormuth
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ quality & safety 31 (3) (2022)
Katerina M Mantila, Anna Maria Gerdina Pasmooij, Christine Erikstrup Hallgreen, Peter G M Mol, Job Frank Martien van Boven
Medication Adherence Measurement Methods in Registration Trials Supporting the Approval of New Medicines: A Cross-Sectional Analysis of Centralized Procedures in the European Union 2010-2020. Clinical pharmacology and therapeutics 112 (5) (2022)
Ann-Katrine Birkelund Mogensen, Helle Christiansen, Marie Louise De Bruin, Christine Erikstrup Hallgreen
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products. Paediatric drugs 24 (6) (2022)
Marianne Botoft Hansen, Lotte Stig Nørgaard, Christine Erikstrup Hallgreen
How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations. Therapeutic innovation & regulatory science 54 (3) (2020)
Maja-Marie Grønfeldt Højer, Marie Louise De Bruin, Arnela Boskovic, Christine Erikstrup Hallgreen
Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018. BMJ open 10 (5) (2020)
Marianne Botoft Hansen, Lotte Stig Nørgaard, Christine Erikstrup Hallgreen
How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations. Therapeutic innovation & regulatory science (2019)

Christine Erikstrup Hallgreen.css-eqlu8i{font-size:small;padding-left:4px;} (Christine E Hallgreen)

Publication Activity (10 Years)

Top Topics

Top Venues

Christine Erikstrup Hallgreen (Christine E Hallgreen)